Clinical trial
Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy…
NCT00136643 · Laval University, Other · Completed
Key facts
| NCT number | NCT00136643 |
|---|---|
| Title | Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women |
| Official title | A Phase I/II Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerance and Acceptability of a Vaginal Gel Containing Sodium Lauryl Sulfate (Invisible Condom®) in Healthy Female Subjects |
| Lead sponsor | Laval University, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Centre Hospitalier de l'Universite Laval (CHUL) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Sexually Transmitted Diseases |
| Intervention type | Drug |
| Interventions | Invisible Condom® |
| Enrollment | 452 |
| Start date | Jun 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Aug 29, 2005 |
| Last update posted | Oct 10, 2007 |
| Countries | Cameroon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: